Email updates

Keep up to date with the latest news and content from Breast Cancer Research and BioMed Central.

Meeting report

The devil is in the methods: lineage tracing, functional screens and sequencing, hormones, tumour-stroma interactions, and expansion of human breast tumours as xenografts

María dM Vivanco1, John Stingl2, Robert B Clarke3 and Mohamed Bentires-Alj4*

Author Affiliations

1 CIC bioGUNECell Biology & Stem Cells UnitParque Tecnológico de Bizkaia, Ed 801A48160 Derio (Bizkaia), Spain

2 Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK

3 Breast Biology Group School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester M20 4BX, UK

4 Friedrich Miescher Institute for Biomedical Research (FMI), Maulbeerstr. 66; CH-4058 Basel, Switzerland

For all author emails, please log on.

Breast Cancer Research 2011, 13:316  doi:10.1186/bcr3021

Published: 14 October 2011

Abstract

The meeting of the European Network for Breast Development and Cancer (ENBDC) on 'Methods in Mammary Gland Development and Cancer' has become an annual international rendezvous for scientists with interests in the normal and neoplastic breast. The third meeting in this series, held in April-May 2011 in Weggis, Switzerland, focussed on functional screens and sequencing, hormones, lineage tracing, tumor-stroma interactions and the expansion of human breast tumours as xenografts.